The codon 64 polymorphism of the β3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients

Metabolism: Clinical and Experimental

Volumn 48, Issue 7, 1999, Pages 853-856

  Pulkkinen, Arto ^a   Kareinen, Anu ^a   Saarinen, Laura ^a   Heikkinen, Sami ^a   Lehto, Seppo ^a   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; INSULIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CODON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RECEPTOR GENE; RISK FACTOR;

EID: 0033061280     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90218-4     Document Type: Article

References (31)

1. Pyörälä K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease; results from two population studies in Finland. Diabetes Care 2:131-141, 1979
2. Ducimitiere P, Eschwege E, Papoz L, et al: Relationship of plasma insulin level to the incidence of myocardial infarction and coronary heart disease mortality in middle-aged population. Diabetologia 19:205-210, 1980
3. Despres J-P, Lamarche B, Mauriege P, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
4. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
5. Genest J, Cohn JS: Clustering of cardiovascular risk factors: Targeting high risk individuals. Am J Cardiol 76:8A-20A, 1995
6. Walston J, Silver K, Bogardus C, et al: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 333:343-347, 1995
7. Fujisawa T, Ikegami H, Yamato E, et al: Association of Trp64Arg mutation of the beta 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 9:349-352, 1996
8. De la Chapelle A: Disease gene mapping in isolated human populations: The example of Finland. J Med Genet 30:857-865, 1993
9. Kittles RA, Perola M, Peltonen L, et al: Dual origins of Finns revealed by Y chromosome haplotype variation. Am J Hum Genet 62:1171-1179, 1998
10. World Health Organization: Diabetes mellitus: Report of a WHO study group. World Health Organ Tech Rep Ser 727:1985
11. World Health Organization: Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA Project). Geneva, Switzerland, World Health Organization (WHO/MNC/82.1 revision 1), 1983
12. Haffner SM, Karhapää P, Mykkänen L, et al: Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 43:212-219, 1994
13. 3-adrenergic receptor gene: Lack of association with NIDDM and features of insulin resistance syndrome. Diabetes Care 20:1319-1323, 1997
14. Karhapää P, Uusitupa M, Voutilainen E, et al: Effects of bezafibrate on insulin sensitivity and glucose tolerance in subjects with familial combined hyperlipidemia. Clin Pharmacol Ther 52:620-626, 1992
15. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 5:45-86, 1985
16. Steele R: Influence of glucose loading and of injected insulin on hepatic glucose production. Ann NY Acad Sci 82:420-430, 1959
17. Cobelli C, Mari A, Ferrannini E: Non-steady state: Error in analysis of Steele's model and development of glucose kinetics. Am J Physiol 252:E679-E689, 1987
18. Penttilä IM, Voutilainen E, Laitinen P, et al: Comparison of different analytical and precipitation methods for the direct estimation of serum high density lipoprotein cholesterol. Scand J Clin Lab Invest 41:353-360, 1984
19. Laakso M, Sarlund H, Mykkänen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231, 1990
20. Khaw K-T, Barrett-Connor E: Family history of heart attack: A modifiable risk factor? Circulation 74:239-244, 1986
21. Rissanen AM: Familial occurrence of coronary heart disease: Effect of age at diagnosis. Am J Cardiol 44:60-66, 1979
22. Koskenvuo M, Kaprio J, Romanov K: Twin studies in metabolic diseases. Ann Med 24:379-381, 1992
23. Fontbonne A, Eschwege E, Cambien F, et al: Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32:300-304, 1989
24. Laakso M, Sarlund H, Salonen R, et al: Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 11:1068-1076, 1991
25. Howard G, O'Leary DH, Zaccaro D, et al: Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817, 1996
26. Widen E, Lehto M, Kanninen T, et al: Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
27. Clement K, Vaisse C, Manning BS, et al: Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354, 1995
28. 3-adrenergic receptor gene. Diabetes 45:1115-1120, 1996
29. Li L, Lönnqvist F, Luthman H, et al: Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39:857-860, 1996
30. 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 40:469-472, 1997
31. 3-adrenergic receptor gene affects basal metabolic rate in obese Finns. Diabetes 46:77-80, 1997